Membranous nephropathy associated with hepatitis C virus infection treated with corticosteroids and Ledipasvir-Sofosbuvir: a case report and review of literature

被引：8
作者：
Weng, Qinjie [1 ]
Li, Xiao [1 ]
Ren, Hong [1 ]
Xie, Jingyuan [1 ]
Pan, Xiaoxia [1 ]
Xu, Jing [1 ]
Chen, Nan [1 ]
机构：
[1] Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Dept Nephrol, Shanghai 200030, Peoples R China
来源：
ONCOTARGET | 2017年 / 8卷 / 13期
关键词：
hepatitis C virus; membranous nephropathy; hepatitis C virus-related glomerulonephritis; Ledipasvir-Sofosbuvir; case report; GENOTYPE; 1; INFECTION; KIDNEY-DISEASE; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; RENAL-DISEASE; HCV; THERAPY; JAPAN; PLUS;
D O I：
10.18632/oncotarget.15397
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Background: Membranous nephropathy (MN) is the most common cause of nephrotic syndrome in adults. As many clinical cases have reported, it may be associated with hepatitis C virus (HCV) infection. Antiviral therapy can be various. Case summary: We report a case of patient with chronic HCV infection and MN, who presented with was proteinuria. He was treated with ledipasvir and sofosbuvir (Harvoni; Gilead Sciences, Foster City, CA) and was found to be virus-free. Conclusion: We have reported this case to provide insight into whether Ledipasvir-Sofosbuvir should be administered for HCV-related glomerulonephritis.
引用
收藏
页码：22299 / 22303
页数：5
相关论文
共 50 条
  • [31] Ledipasvir-sofosbuvir in patients with hepatitis C virus genotype 5 infection: an open-label, multicentre, single-arm, phase 2 study
    Abergel, Armand
    Asselah, Tarik
    Metivier, Sophie
    Kersey, Kathryn
    Jiang, Deyuan
    Mo, Hongmei
    Pang, Phillip S.
    Samuel, Didier
    Loustaud-Ratti, Veronique
    LANCET INFECTIOUS DISEASES, 2016, 16 (04) : 459 - 464
  • [32] Development of diffuse large B-cell lymphoma after sofosbuvir-ledipasvir treatment for chronic hepatitis C: A case report and literature review
    Sakai, Hiroyasu
    Miwa, Takao
    Ikoma, Yoshikazu
    Hanai, Tatsunori
    Nakamura, Nobuhiko
    Imai, Kenji
    Kitagawa, Junichi
    Shirakami, Yohei
    Kanemura, Nobuhiro
    Suetsugu, Atsushi
    Takai, Koji
    Shiraki, Makoto
    Shimizu, Masahito
    MOLECULAR AND CLINICAL ONCOLOGY, 2020, 13 (03) : 1 - 6
  • [33] Membranous nephropathy associated with multicentric Castleman's disease that was successfully treated with tocilizumab: a case report and review of the literature
    Saiki, Ryosuke
    Katayama, Kan
    Hirabayashi, Yosuke
    Oda, Keiko
    Fujimoto, Mika
    Murata, Tomohiro
    Nakajima, Ayako
    Dohi, Kaoru
    BMC NEPHROLOGY, 2021, 22 (01)
  • [34] Prophylactic Treatment of Hepatitis C Virus Infection After Kidney Transplantation with the Combination of Glecaprevir/Pibrentasvir and Sofosbuvir in a Highly Sensitized Hepatitis C Virus-Negative Recipient: A Case Report and Review of the Literature
    Mikic, Tanja Belcic
    Sterle, Igor
    Maticic, Mojca
    Arnol, Miha
    BIOMEDICINES, 2025, 13 (02)
  • [35] Pharmacokinetic Interactions between Simeprevir and Ledipasvir in Treatment Naive Hepatitis C Virus Genotype 1-Infected Patients without Cirrhosis Treated with a Simeprevir-Sofosbuvir-Ledipasvir Regimen
    Bourgeois, Stefan
    Horsmans, Yves
    Nevens, Frederik
    van Vlierberghe, Hans
    Moreno, Christophe
    Beumont, Maria
    Vijgen, Leen
    van Eygen, Veerle
    Luo, Donghan
    Hillewaert, Vera
    Van Remoortere, Pieter
    van de Logt, Jolanda
    Ouwerkerk-Mahadevan, Sivi
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2017, 61 (12)
  • [36] Sofosbuvir and ledipasvir decreased nephrotic syndrome caused by IgA nephropathy with a membranoproliferative pattern of injury in hepatitis C virus-induced cirrhosis: a case report
    Zhang, Xiaohao
    Zhou, Jing
    Li, Canming
    Rao, Jialing
    Li, Yuanqing
    Zhang, Jun
    Peng, Hui
    ANNALS OF TRANSLATIONAL MEDICINE, 2022, 10 (08)
  • [37] Efficacy and Safety of Generic Sofosbuvir/Ledipasvir Fixed-Dose Combination in Iranian Patients with Chronic Hepatitis C Virus Infection
    Sharafi, Heidar
    Nikbin, Mehri
    Alavian, Seyed Hoda
    Behnava, Bita
    Alavian, Seyed Moayed
    HEPATITIS MONTHLY, 2017, 17 (06)
  • [38] Effect of HIV co-infection on adherence to a 12-week regimen of hepatitis C virus therapy with ledipasvir and sofosbuvir
    Townsend, Kerry
    Petersen, Tess
    Gordon, Lori A.
    Kohli, Anita
    Nelson, Amy
    Seamon, Cassie
    Gross, Chloe
    Tang, Lydia
    Osinusi, Anu
    Polis, Michael A.
    Masur, Henry
    Kottilil, Shyam
    AIDS, 2016, 30 (02) : 261 - 266
  • [39] Ledipasvir and Sofosbuvir in the Treatment of Early Hepatitis C Virus Infection in HIV-Infected Men
    Palaniswami, Paari M.
    El Sayed, Ahmed
    Asriel, Benjamin
    Carollo, Jesse R.
    Fierer, Daniel S.
    OPEN FORUM INFECTIOUS DISEASES, 2018, 5 (10):
  • [40] Successful Treatment of Chronic Hepatitis C Virus Infection With Sofosbuvir and Ledipasvir in Renal Transplant Recipients
    Eisenberger, Ute
    Guberina, Hana
    Willuweit, Katharina
    Bienholz, Anja
    Kribben, Andreas
    Gerken, Guido
    Witzke, Oliver
    Herzer, Kerstin
    TRANSPLANTATION, 2017, 101 (05) : 980 - 986
12345